Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS)
Abroad (travel likely)RecruitingPHASE1
Conditions
Alcohol Use Disorder · Weight Loss · Bariatric Surgery Patients
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Yale School of Medicine, New Haven, Connecticut, United States
Study leads
Valentina Ivezaj, PhD
Principal Investigator
Yale University